SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-053689
Filing Date
2024-02-29
Accepted
2024-02-29 17:27:02
Documents
16
Period of Report
2024-02-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d799495d8k.htm   iXBRL 8-K 25556
2 EX-5.1 d799495dex51.htm EX-5.1 9888
6 GRAPHIC g799495g0227131557931.jpg GRAPHIC 14311
  Complete submission text file 0001193125-24-053689.txt   181477

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcyt-20240229.xsd EX-101.SCH 2852
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcyt-20240229_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcyt-20240229_pre.xml EX-101.PRE 11262
17 EXTRACTED XBRL INSTANCE DOCUMENT d799495d8k_htm.xml XML 3641
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

IRS No.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 24705289
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)